Sumitomo Pharma America (SMPA)

Sumitomo Pharma Group (the “Group”) is dedicated to enhancing healthcare and enriching the lives of people globally. This commitment is realized through diverse approaches including the development of innovative pharmaceuticals and healthcare solutions. As a research and development-oriented pharmaceutical company, Sumitomo Pharma continuously undertakes challenges to deliver cutting-edge products and services that address critical health needs around the world.

Sumitomo Pharma has established a robust operational framework in Japan, the United States, and other regions, fostering strong business foundations. Key research and development focus areas include oncology, women's health, urology, psychiatry, and neurology. Notably, the Group aims to position itself as a Global Specialized Player by 2033, emphasizing its commitment to driving innovation in the pharmaceutical industry. With its expanding portfolio and commitment to sustainability, the Group actively contributes to society through value creation based on innovative research and development activities, ultimately striving for better healthcare outcomes.